Heart failure and the lung

Circulation Journal

Volumn 74, Issue 12, 2010, Pages 2507-2516

  Kee, Kirk ^a   Naughton, Matthew T ^b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Acute decompensated heart failure; Heart failure; Positive airway pressure; Pulmonary disease; Sleep apnoea

Indexed keywords

BRONCHUS MUSCLE; CAPILLARY PERMEABILITY; CARDIOPULMONARY INSUFFICIENCY; CENTRAL SLEEP APNEA SYNDROME; CLINICAL TRIAL; DISEASE EXACERBATION; FLUID BALANCE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HUMAN; HYDROSTATIC PRESSURE; LUNG CAPILLARY PRESSURE; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG EDEMA; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; LYMPHATIC DRAINAGE; MUSCLE HYPERTROPHY; NONHUMAN; ONCOTIC PRESSURE; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; STRESS FRACTURE; THERAPY EFFECT; THORAX PRESSURE; TOTAL LUNG CAPACITY; VASCULAR FIBROSIS;

AIRWAY OBSTRUCTION; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; LUNG; PULMONARY EDEMA; PULMONARY FIBROSIS; SLEEP APNEA SYNDROMES;

EID: 78649717370     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0869     Document Type: Review

References (84)

1. Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, et al. Prevention of heart failure: A scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008; 117: 2544-2565.
2. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Confirmation of a heart failure epidemic: Findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002; 39: 60-69.
3. Gehlbach BK, Geppert E. The pulmonary manifestations of left heart failure. Chest 2004; 125: 669-682.
4. Uhley HN, Leeds SE, Sampson JJ, Friedman M. Role of pulmonary lymphatics in chronic pulmonary edema. Circ Res 1962; 11: 966-970.
5. Broaddus VC, Wiener-Kronish JP, Staub NC. Clearance of lung edema into the pleural space of volume-loaded anesthetized sheep. J Appl Physiol 1990; 68: 2623-2630.
6. West JB. Pulmonary pathophysiology the essentials. 7th edn. Philadelphia: Lippincott Williams & Wilkins, 2008.
7. Tsukimoto K, Mathieu-Costello O, Prediletto R, Elliott AR, West JB. Ultrastructural appearances of pulmonary capillaries at high transmural pressures. J Appl Physiol 1991; 71: 573-582.
8. Costello ML, Mathieu-Costello O, West JB. Stress failure of alveolar epithelial cells studied by scanning electron microscopy. Am Rev Respir Dis 1992; 145: 1446-1455.
9. Parker F, Weiss S. The nature and significance of the structural changes in the lungs in mitral stenosis. Am J Pathol 1936; 12: 573-598.
10. Haworth SG, Hall SM, Panja M. Peripheral pulmonary vascular and airway abnormalities in adolescents with rheumatic mitral stenosis. Int J Cardiol 1988; 18: 405-416.
11. Kay JM, Edwards FR. Ultrastructure of the alveolar capillary wall in mitral stenosis. J Pathol 1973; 109: Pvi.
12. Jordan SC, Hicken P, Watson DA, Heath D, Whitaker W. Pathology of the lungs in mitral stenosis in relation to respiratory function and pulmonary haemodynamics. Br Heart J 1966; 28: 101-107.
13. Aber CP, Campbell JA. Significance of changes in the pulmonary diffusing capacity in mitral stenosis. Thorax 1965; 20: 135-145.
14. Jasmin JF, Calderone A, Leung TK, Villeneuve L, Dupuis J. Lung structural remodeling and pulmonary hypertension after myocardial infarction: Complete reversal with irbesartan. Cardiovasc Res 2003; 58: 621-631.
15. Huang W, Kingsbury MP, Turner MA, Donnelly JL, Flores NA, Sheridan DJ. Capillary filtration is reduced in lungs adapted to chronic heart failure: Morphological and haemodynamic correlates. Cardiovasc Res 2001; 49: 207-217.
16. Heard BE, Steiner RE, Herdan A, Gleason D. Oedema and fibrosis of the lungs in left ventricular failure. Br J Radiol 1968; 41: 161-171.
17. Lee YS. Electron microscopic studies on the alveolar-capillary barrier in the patients of chronic pulmonary edema. Jpn Circ J 1979; 43: 945-954.
18. Townsley MI, Fu Z, Mathieu-Costello O, West JB. Pulmonary microvascular permeability: Responses to high vascular pressure after induction of pacing-induced heart failure in dogs. Circ Res 1995; 77: 317-325.
19. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1988; 7: 331-336.
20. Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992; 19: 48-54.
21. Boni E, Bezzi M, Carminati L, Corda L, Grassi V, Tantucci C. Expiratory flow limitation is associated with orthopnea and reversed by vasodilators and diuretics in left heart failure. Chest 2005; 128: 1050-1057.
22. Duguet A, Tantucci C, Lozinguez O, Isnard R, Thomas D, Zelter M, et al. Expiratory flow limitation as a determinant of orthopnea in acute left heart failure. J Am Coll Cardiol 2000; 35: 690-700.
23. Torchio R, Gulotta C, Greco-Lucchina P, Perboni A, Avonto L, Ghezzo H, et al. Orthopnea and tidal expiratory flow limitation in chronic heart failure. Chest 2006; 130: 472-479.
24. Chiu KL, Ryan CM, Shiota S, Ruttanaumpawan P, Arzt M, Haight JS, et al. Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med 2006; 174: 1378-1383.
25. Muir AL, Flenley DC, Kirby BJ, Sudlow MF, Guyatt AR, Brash HM. Cardiorespiratory effects of rapid saline infusion in normal man. J Appl Physiol 1975; 38: 786-775.
26. Puri S, Dutka DP, Baker BL, Hughes JM, Cleland JG. Acute saline infusion reduces alveolar-capillary membrane conductance and increases airflow obstruction in patients with left ventricular dysfunction. Circulation 1999; 99: 1190-1196.
27. Sharp JT, Griffith GT, Bunnell IL, Greene DG. Ventilatory mechanics in pulmonary edema in man. J Clin Invest 1958; 37: 111-117.
28. Light RW, George RB. Serial pulmonary function in patients with acute heart failure. Arch Intern Med 1983; 143: 429-433.
29. McNicol MW, Kirby BJ, Bhoola KD, Everest ME, Price HV, Freedman SF. Pulmonary function in acute myocardial infarction. Br Med J 1965; 2: 1270-1273.
30. Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, et al. Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med 2008; 264: 361-369.
31. Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, et al. The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail 2010; 12: 685-691.
32. Rhodes KM, Evemy K, Nariman S, Gibson GJ. Relation between severity of mitral valve disease and results of routine lung function tests in non-smokers. Thorax 1982; 37: 751-755.
33. Frank NR, Cugell DW, Gaensler EA, Ellis LB. Ventilatory studies in mitral stenosis; a comparison with findings in primary pulmonary disease. Am J Med 1953; 15: 60-76.
34. Morris MJ, Smith MM, Clarke BG. Lung mechanics after cardiac valve replacement. Thorax 1980; 35: 453-460.
35. Olson TP, Beck KC, Johnson JB, Johnson BD. Competition for intrathoracic space reduces lung capacity in patients with chronic heart failure: A radiographic study. Chest 2006; 130: 164-171.
36. Wright RS, Levine MS, Bellamy PE, Simmons MS, Batra P, Stevenson LW, et al. Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest 1990; 98: 816-820.
37. Dimopoulou I, Daganou M, Tsintzas OK, Tzelepis GE. Effects of severity of long-standing congestive heart failure on pulmonary function. Respir Med 1998; 92: 1321-1325.
38. Agostoni P, Bussotti M, Cattadori G, Margutti E, Contini M, Muratori M, et al. Gas diffusion and alveolar capillary unit in chronic heart failure. Eur Heart J 2006; 27: 2538-2543.
39. Siegel JL, Miller A, Brown LK, DeLuca A, Teirstein AS. Pulmonary diffusing capacity in left ventricular dysfunction. Chest 1990; 98: 550-553.
40. Daganou M, Dimopoulou I, Alivizatos PA, Tzelepis GE. Pulmonary function and respiratory muscle strength in chronic heart failure: Comparison between ischaemic and idiopathic dilated cardiomyopathy. Heart 1999; 81: 618-620.
41. Mettauer B, Lampert E, Charloux A, Zhao QM, Epailly E, Oswald M, et al. Lung membrane diffusing capacity, heart failure, and heart transplantation. Am J Cardiol 1999; 83: 62-67.
42. Al-Rawas OA, Carter R, Stevenson RD, Naik SK, Wheatley DJ. The alveolar-capillary membrane diffusing capacity and the pulmonary capillary blood volume in heart transplant candidates. Heart 2000; 83: 156-160.
43. Bussieres LM, Pflugfelder PW, Ahmad D, Taylor AW, Kostuk WJ. Evolution of resting lung function in the first year after cardiac transplantation. Eur Respir J 1995; 8: 959-962.
44. Niset G, Ninane V, Antoine M, Yernault JC. Respiratory dysfunction in congestive heart failure: Correction after heart transplantation. Eur Respir J 1993; 6: 1197-1201.
45. Ravenscraft SA, Gross CR, Kubo SH, Olivari MT, Shumway SJ, Bolman RM 3rd, et al. Pulmonary function after successful heart transplantation: One year follow-up. Chest 1993; 103: 54-58.
46. Hosenpud JD, Stibolt TA, Atwal K, Shelley D. Abnormal pulmonary function specifically related to congestive heart failure: Comparison of patients before and after cardiac transplantation. Am J Med 1990; 88: 493-496.
47. Habedank D, Ewert R, Hummel M, Wensel R, Hetzer R, Anker SD. Changes in exercise capacity, ventilation, and body weight following heart transplantation. Eur J Heart Fail 2007; 9: 310-316.
48. Nanjo S, Yamashiro Y, Fujimoto S, Yamashina S, Nakanishi R, Fukunaga S, et al. Evaluation of sympathetic activity by 123Imetaiodobenzylguanidine myocardial scintigraphy in dilated cardiomyopathy patients with sleep breathing disorder. Circ J 2009; 73: 686-690.
49. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007; 49: 2028-2034.
50. Kee K, Naughton MT. Heart failure and sleep-disordered breathing: Mechanisms, consequences and treatment. Curr Opin Pulm Med 2009; 15: 565-570.
51. Javaheri S. Sleep disorders in systolic heart failure: A prospective study of 100 male patients: The final report. Int J Cardiol 2006; 106: 21-28.
52. Schulz R, Blau A, Borgel J, Duchna HW, Fietze I, Koper I, et al. Sleep apnoea in heart failure. Eur Respir J 2007; 29: 1201-1205.
53. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160: 1101-1106.
54. Naughton M, Benard D, Tam A, Rutherford R, Bradley TD. Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 1993; 148: 330-338.
55. Solin P, Roebuck T, Johns DP, Walters EH, Naughton MT. Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 2000; 162: 2194-2200.
56. Solin P, Kaye DM, Little PJ, Bergin P, Richardson M, Naughton MT. Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 2003; 123: 1119-1126.
57. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995; 152: 473-479.
58. Szollosi I, Thompson BR, Krum H, Kaye DM, Naughton MT. Impaired pulmonary diffusing capacity and hypoxia in heart failure correlates with central sleep apnea severity. Chest 2008; 134: 67-72.
59. Redolfi S, Yumino D, Ruttanaumpawan P, Yau B, Su MC, Lam J, et al. Relationship between overnight rostral fluid shift and Obstructive Sleep Apnea in nonobese men. Am J Respir Crit Care Med 2009; 179: 241-246.
60. Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, et al. Nocturnal rostral fluid shift: A unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010; 121: 1598-1605.
61. Solin P, Snell GI, Williams TJ, Naughton MT. Central sleep apnoea in congestive heart failure despite vagal denervation after bilateral lung transplantation. Eur Respir J 1998; 12: 495-498.
62. Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005; 353: 2025-2033.
63. Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: A post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007; 115: 3173-3180.
64. Dohi T, Kasai T, Narui K, Ishiwata S, Ohno M, Yamaguchi T, et al. Bi-level positive airway pressure ventilation for treating heart failure with central sleep apnea that is unresponsive to continuous positive airway pressure. Circ J 2008; 72: 1100-1105.
65. Fietze I, Blau A, Glos M, Theres H, Baumann G, Penzel T. Bilevel positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Med 2008; 9: 652-659.
66. Noda A, Izawa H, Asano H, Nakata S, Hirashiki A, Murase Y, et al. Beneficial effect of bilevel positive airway pressure on left ventricular function in ambulatory patients with idiopathic dilated cardiomyopathy and central sleep apnea-hypopnea: A preliminary study. Chest 2007; 131: 1694-1701.
67. Kohnlein T, Welte T, Tan LB, Elliott MW. Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. Eur Respir J 2002; 20: 934-941.
68. Philippe C, Stoica-Herman M, Drouot X, Raffestin B, Escourrou P, Hittinger L, et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 2006; 92: 337-342.
69. Bitter T, Westerheide N, Faber L, Hering D, Prinz C, Langer C, et al. Adaptive servoventilation in diastolic heart failure and Cheyne Stokes respiration. Eur Res J 2010; 36: 385-392.
70. Masip J, Roque M, Sanchez B, Fernandez R, Subirana M, Exposito JA. Noninvasive ventilation in acute cardiogenic pulmonary edema: Systematic review and meta-analysis. JAMA 2005; 294: 3124-3130.
71. Petersen JW, Felker GM. Inflammatory biomarkers in heart failure. Congest Heart Fail 2006; 12: 324-328.
72. Winck JC, Azevedo LF, Costa-Pereira A, Antonelli M, Wyatt JC. Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema--a systematic review and metaanalysis. Crit Care 2006; 10: R69.
73. Peter JV, Moran JL, Phillips-Hughes J, Graham P, Bersten AD. Effect of non-invasive positive pressure ventilation (NIPPV) onmortality in patients with acute cardiogenic pulmonary oedema: A meta-analysis. Lancet 2006; 367: 1155-1163.
74. Fernandez Mondejar E, Vazquez Mata G, Cardenas A, Mansilla A, Cantalejo F, Rivera R. Ventilation with positive end-expiratory pressure reduces extravascular lung water and increases lymphatic flow in hydrostatic pulmonary edema. Crit Care Med 1996; 24: 1562-1567.
75. Leithner C, Podolsky A, Globits S, Frank H, Neuhold A, Pidlich J, et al. Magnetic resonance imaging of the heart during positive endexpiratory pressure ventilation in normal subjects. Crit Care Med 1994; 22: 426-432.
76. Choy DS, Jacobson M, Chervin R. Dependent edema and ascites associated with CPAP/BiPAP treatment of sleep apnea. Sleep Med 2006; 7: 594.
77. Butler GC, Naughton MT, Rahman MA, Bradley TD, Floras JS. Continuous positive airway pressure increases heart rate variability in congestive heart failure. J Am Coll Cardiol 1995; 25: 672-679.
78. Barach AL, Swenson P. Effect of breathing gases under positive pressure on lumens of small and medium-sized bronchi. Arch Intern Med 1939; 63: 946-948.
79. Lenique F, Habis M, Lofaso F, Dubois-Rande JL, Harf A, Brochard L. Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure. Am J Respir Crit Care Med 1997; 155: 500-505.
80. Naughton MT, Rahman MA, Hara K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 1995; 91: 1725-1731.
81. Robertson CH Jr, Pagel MA, Johnson RL Jr. The distribution of blood flow, oxygen consumption, and work output among the respiratory muscles during unobstructed hyperventilation. J Clin Invest 1977; 59: 43-50.
82. Kaye DM, Mansfield D, Naughton MT. Continuous positive airway pressure decreases myocardial oxygen consumption in heart failure. Clin Sci (Lond) 2004; 106: 599-603.
83. Bellemare F, Grassino A. Evaluation of human diaphragm fatigue. J Appl Physiol 1982; 53: 1196-1206.
84. Bellemare F, Grassino A. Effect of pressure and timing of contraction on human diaphragm fatigue. J Appl Physiol 1982; 53: 1190-1195.